Seagen
Biotechnology-Research
Industry Category
Business Keywords
Company Description
Seagen is a leading biotechnology research company committed to developing innovative cancer treatments. With a focus on improving the lives of people living with cancer, Seagen has established itself as a key player in the biotechnology industry.
Located at Primary: 21823 30th Dr SE, Bothell, Washington 98021, US, Seagen specializes in pioneering antibody-drug conjugate (ADC) technology and other advanced therapies. The company's dedication to scientific leadership ensures the continuous development of groundbreaking solutions for various types of cancer, including Non-Hodgkin lymphoma, blood cancers, bladder cancer, and Hodgkin lymphoma.
Seagen’s mission is to bring life-saving treatments to those in need, and its contributions to the cancer community are significant. Discover more about Seagen and its ongoing advancements in biotechnology. We invite the manager of Seagen to create a customized and exclusive company showcase and product listing on our platform.
Seagen est une entreprise de recherche biotechnologique de premier plan, engagée dans le développement de traitements innovants contre le cancer. En mettant l'accent sur l'amélioration de la vie des personnes atteintes de cancer, Seagen s'est imposée comme un acteur clé de l'industrie biotechnologique.
Située à Primary: 21823 30th Dr SE, Bothell, Washington 98021, US, Seagen se spécialise dans la technologie pionnière des conjugués anticorps-médicaments (ADC) et autres thérapies avancées. Le dévouement de l'entreprise au leadership scientifique garantit le développement continu de solutions révolutionnaires pour divers types de cancer, notamment le lymphome non hodgkinien, les cancers du sang, le cancer de la vessie et le lymphome hodgkinien.
La mission de Seagen est d'apporter des traitements qui sauvent des vies à ceux qui en ont besoin, et ses contributions à la communauté du cancer sont significatives. Découvrez plus d'informations sur Seagen et ses progrès continus dans le domaine de la biotechnologie. Nous invitons le responsable de Seagen à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare Seagen with 1 companies in Biotechnology-Research
| Comparison Field |
SeagenMain Company |
Iksuda TherapeuticsView Profile |
|---|---|---|
|
Founded Year
|
— | |
|
Company Size
|
— | 11-50 |
|
City
|
Bothell, Washington | Newcastle Upon Tyne, Tyne and Wear |
|
Country
|
United States | United Kingdom |
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Biotechnology
Cancer Treatment
Antibody-Drug Conjugates
Oncology
Drug Development
Pharmaceuticals
Monoclonal Antibodies
Drug development
Non-Hodgkin lymphoma
Blood cancers
Monoclonal antibody-based therapies for cancer
Cancer drug development
Conjugation Chemistry
Bladder cancer
Hodgkin lymphoma
|
19 Total
3 Common
16 Unique
Match
20%
Common Skills:
Biotechnology
Cancer Treatment
Drug Development
Unique Skills:
ADC Stability
ADCs
Antibodies
Antibody Drug Conjugate
Bioconjugation
Cancer research
+10
|
2
Total Companies—
Oldest Founded2
Countries31
Unique SkillsSimilar Companies
Other organizations in the same industry
Hamilton Bonaduz AG
Biotechnology-ResearchWe drive innovation to improve people’s lives.
Abselion
Biotechnology-ResearchPrecision Made Practical
Vexillum LLC
Biotechnology-ResearchVexillum offers prospective and retrospective bio sample collections for clients through its own IRB...
Alternative Company Names
This company is also known as